Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-22

Clinical Trial Update: ArcadiusXP L Post Market Clinical Follow-Up

View source ↗

Summary

A post-market clinical follow-up study of the ArcadiusXP L device for degenerative disc disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ArcadiusXP L

Snippet

Sponsor: Aesculap AG | Conditions: Degenerative Disc Disease | Status: COMPLETED